Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Imaging Neuroscience (Cambridge, Mass.)|June 15, 2026
Detection of slowly expanding lesions in people with multiple sclerosis using MRI: A scoping reviewMalo Gicquel, Anne Kerbrat, Benoit CombèsBriefings in Bioinformatics|June 9, 2025
Alpha_Mesh_Swc: automatic and robust surface mesh generation from the skeleton description of brain cellsAlex McSweeney-Davis, Chengran Fang, Emmanuel Caruyer, et al.Imaging Neuroscience (Cambridge, Mass.)|December 1, 2025
LesionSCynth: A simple parametric lesion synthesis method to improve spinal cord lesion segmentation in low-data scenariosRicky Walsh, Prabhjot Kaur, Davood Karimi, et al.Brain and Behavior|September 30, 2023
Effectiveness of regional diffusion MRI measures in distinguishing multiple sclerosis abnormalities within the cervical spinal cordHaykel Snoussi, Julien Cohen-Adad, Benoît Combès, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosisKevin Ahrweiller, Chloé Rousseau, Emmanuelle Le Page, et al.Journal of Neurology|June 9, 2019
Joint assessment of brain and spinal cord motor tract damage in patients with early RRMS: predominant impact of spinal cord lesions on motor functionRaphaël Chouteau, Benoit Combès, Elise Bannier, et al.Journal of Neurology|September 19, 2022
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosisMaëlle Chappuis, Chloé Rousseau, Emma Bajeux, et al.NMR in Biomedicine|April 28, 2026
Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple SclerosisBenjamin Streichenberger, Mathieu Santin, Ludovic de Rochefort, et al.Multiple Sclerosis and Related Disorders|March 31, 2023
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)Simon Lamy, David Veillard, Hélène Doyen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-upAnne Kerbrat, Benoit Combès, Olivier Commowick, et al.Pageof 6